25 results on '"Arguelles-Arias F"'
Search Results
2. P572 Evaluation of safety, pharmacokinetics and efficacy of oral treatment with OST-122 in patients with moderate to severe ulcerative colitis: A Phase Ib/IIa, randomized, double blind, placebo controlled clinical trial
3. Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study
4. Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFalpha used for the treatment of IBD: Results from the VERNE study
5. Comorbidities and epidemiological risk factor but not immunosuppressive therapies increase the risk of COVID-19 in Inflammatory Bowel Disease (IBD): An ENEIDA-based, case-control study
6. Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study
7. Impact of comorbidities on anti-TNF alpha response and relapse in patients with inflammatory bowel disease: the VERNE study
8. Long-term evolution after anti-TNF discontinuation in patients with inflammatory bowel disease (IBD): A multicentre study
9. How to incorporate patients preference into ulcerative colitis current clinical management: initial document from a Spanish multidisciplinary steering committee
10. Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease
11. Role of capsule endoscopy in alarm features and non-responsive celiac disease: A European multicenter study
12. P214 How to incorporate patients preference into ulcerative colitis current clinical management: initial document from a Spanish multidisciplinary steering committee
13. Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
14. Capsule endoscopy in young patients with iron deficiency anaemia and negative bidirectional gastrointestinal endoscopy
15. Effectiveness and safety of ustekinumab in bio-naïve Crohn’s disease patients: a multicentre observational retrospective study
16. Screening of Hepatocellular Carcinoma in Autoimmune Cirrhosis: More Value Than Costs?
17. Patients' perceptions of the impact of ulcerative colitis on social and professional life: results from the UC-LIFE survey of outpatient clinics in Spain
18. Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices
19. Rapidity of onset of response to adalimumab in luminal Crohn's disease. Data from RAPIDA trial
20. Safety and efficacy of infliximab biosimilar (Remsima (c)) in ulcerative colitis disease patients in clinical practice: results after 6-months treatment
21. More than 10 years of experience of use methotrexate in Crohn's disease at Macarena Hospital, Sevilla, Spain
22. More than 10 years of experience of use methotrexate in Ulcerative colitis at Macarena Hospital, Sevilla, Spain
23. Safety and efficacy of infliximab biosimilar (Remsima (c)) in Crohn's disease patients in clinical practice: results after 6 months of treatment
24. Long-term evolution after anti-TNF discontinuation in patients with inflammatory bowel disease (IBD): A multicentre study
25. Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.